Buprenorphine Tablet
Product Images NDC 62756-459

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 62756-459). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine-label-2mg (Buprenorphine Label 2mg)

Buprenorphine-label-2mg (Buprenorphine Label 2mg)
This is a label for Buprenorphine Sublingual Tablets with NDC number 62756-459-83 and a quantity of 30 tablets. The label instructs the pharmacist to dispense with medication guide for each patient. It also mentions that the package is open for full labeling.*
FDA Label Image

Buprenorphine-label-8mg (Buprenorphine Label 8mg)

Buprenorphine-label-8mg (Buprenorphine Label 8mg)
This is a label for buprenorphine sublingual tablets with NDC number 62756-460-83. The pharmacist is advised to dispense the medication with a medication guide to each patient. The label also includes a lot number (AAAAEHA) and an expiration date (MMYYYY). The dosage strength is not entirely clear, but may be between 5-8mg H.*
FDA Label Image

Buprenorphine-figure (Buprenorphine Figure)

FDA Label Image

Buprenorphine-str (Buprenorphine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.